Prescribing in the Face of Beta-Lactam Allergy Indicated in the Medical Record
Presented by
the Massachusetts Medical Society in collaboration with the American Medical
Association
This educational webinar is one in a series of three free
webinars that provides valuable insight into selecting the appropriate personal
protective equipment for standard precautions during patient interactions,
ensuring swift implementation of precautions for patients with transmissible
infections, and navigating complex clinical scenarios involving laboratory
tests and antibiotic prescriptions.
Prescribing antibiotics for individuals with a documented
beta-lactam allergy requires careful consideration due to the potential risks
associated with allergic reactions. In this module, Dr. Kimberly Blumenthal, Co-Director of the Clinical Epidemiology
Research Center and Director of Research in the Center for Drug Vaccine and
Allergy at Massachusetts General Hospital, discusses prescribing antibiotics
for patients with a documented beta-lactam allergy.
To access the other two webinars in this series, click here.
Faculty
Activity Director
Alfred DeMaria Jr., MD,
FIDSA, FSHEA
Medical and Laboratory
Consultant, Bureau of Infectious Disease and Laboratory Sciences
Massachusetts Department of Public Health
Dr. DeMaria is a Medical and Laboratory Consultant at the Massachusetts Department of Public Health where he previously served as Medical Director of the Bureau of Infectious Disease and Laboratory Sciences, and for many years as State Epidemiologist
for Massachusetts, as well as in several other roles. He is a graduate of Boston University and Harvard Medical School. He trained in internal medicine at Montefiore Medical Center in The Bronx, New York and in infectious diseases at Boston City Hospital
and the Boston University School of Medicine. Dr. DeMaria is a Fellow of the Infectious Diseases Society of America and of the Society for Healthcare Epidemiology of America. He currently is a member or advisor on multiple committees of the Massachusetts
Medical Society, as well as serving on the boards of the Grimes King Foundation, the Boston Medical Library, The CSTE Foundation and as President of the Board of Directors of The Public Health Museum. He is a past president of the Council of State
and Territorial Epidemiologists, the Massachusetts Infectious Diseases Society and the Northeast Branch of the American Society for Microbiology.
Moderator
Simone S. Wildes, MD, FACP, FIDSA
Vice Chair of Infection Prevention
Committee and Co-Chair of Antimicrobial Service Committee, South Shore
Hospital; Clinical Assistant Professor of Medicine, Tufts University School of Medicine
Dr. Wildes is an infectious disease physician, public health expert, and ABC News medical contributor. She works at South Shore Health in Weymouth MA. Dr. Wildes is actively involved with the Massachusetts Medical Society as an executive board member,
chair of the Committee on Diversity, and vice chair of the Committee on Public Health. She is also a member of the Massachusetts Department of Public Health’s COVID-19 Health Equity advisory group.
Dr. Wildes earned her bachelor’s degree from Barry University in Florida and her medical degree from the Loma Linda University School of Medicine in California. She completed her internship, residency and infectious disease fellowship at Hahnemann University
Hospital and is currently a clinical assistant professor of medicine at Tufts Medical Center. She is a member of the Infectious Disease Society of America and the American College of Physicians. She also volunteers at her local church in Boston as
its health director and is involved with Boston’s Faith-based Cancer Disparities Network.
Presenter
Kimberly G. Blumenthal, MD, MSc, FAAAAI, FACAAI
Associate Professor of Medicine, Harvard Medical
School; Co-Director, Rheumatology and Allergy Clinical Epidemiology Research
Center, Mongan Institute, Massachusetts General Hospital; Director of Research,
Drug and Vaccine Allergy Center, Massachusetts General Hospital
Kimberly
Blumenthal, MD, MSc is an Allergist/Immunologist and clinical researcher at
Massachusetts General Hospital and Associate Professor of Medicine at Harvard
Medical School. She is the Co-Director of the Clinical Epidemiology Research
Center and Director of Research in the Center for Drug and Vaccine Allergy. Dr.
Blumenthal performs drug and vaccine allergy research that uses methods of
epidemiology, informatics, economics, decision science, and implementation
science. Her research has been funded by the National Institute of Health,
Agency for Healthcare Research and Quality, and foundations, including the
American Academy of Allergy, Asthma, and Immunology Foundation and CRICO, the
risk management foundation of Harvard Medical School. Dr. Blumenthal is
internationally recognized for identifying the morbidity and mortality
associated with unverified penicillin allergies and creating innovative
approaches to the evaluation of penicillin and cephalosporin antibiotic
allergies in diverse patient settings. Dr. Blumenthal has authored more than
170 peer-reviewed publications including leading high-impact manuscripts to
publication in journals such as NEJM, Lancet, JAMA, and
the BMJ.
Dr. Blumenthal
graduated from Columbia University with a BA in Economics. She studied medicine
at Yale University School of Medicine, before training at the Massachusetts
General Hospital for Internal Medicine and Allergy and Immunology. She
completed a Master of Science in Clinical Epidemiology at the Harvard T.H. Chan
School of Public Health in 2017.
Intended Audience
This activity is designed for physicians, physicians-in-training, and other health care leaders, professionals and students.
Course Objective
Upon completion of this activity, learners should be able to:
- Prescribe
appropriate antimicrobial therapy to patients with a history of beta-lactam
antibiotic allergy and achieve more confidence in de-labeling allergy
Course Fees
Massachusetts Medical Society (MMS) Physician Member: Free
MMS Resident/Student Member: Free
Non-Member Physician: Free
Non-Members Resident/Student: Free
Allied Health Professional/Other: Free
Acknowledgements
Project Firstline is a national collaborative led by the U.S. Centers for Disease Control and Prevention (CDC) to provide infection control training and education to frontline health care workers and public health personnel. AMA has partnered with Project Firstline, as supported through Cooperative Agreement CDC-RFA-CK20-2003. The Massachusetts Medical Society is proud to collaborate with AMA and Project Firstline in this educational activity. CDC is an agency within the Department of Health and Human Services (HHS). The contents of this event do not necessarily represent the policies of CDC or HHS and should not be considered an endorsement by the Federal Government.
The MMS appreciates the valuable advice received from staff of the Massachusetts Department of Public Health (MDPH), Bureau of Infectious Disease and Laboratory Sciences, and the MDPH Technical Advisory Group on Healthcare-Associated Infection and Antimicrobial Resistance as to observed knowledge and practice gaps.
Accreditation & Credit Information
Accreditation
Statement
The Massachusetts Medical Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit
Designation Statement
The Massachusetts Medical Society designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation
in the activity.
This activity meets the criteria for the Massachusetts Board of Registration in Medicine for risk management study.
National Commission on Certification of Physician Assistants (NCCPA)
Physician Assistants may claim a maximum of 0.50 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by
ACCME or a recognized state medical society.
Exam/Assessment: A score of 70% or higher is required to receive AMA PRA Category 1 Credit(s)™.
Activity Term
Original Release Date: February 5, 2024
Review Date(s): N/A
Termination Date: February 5, 2027
Format and Estimated Time to Complete: Video recording, 30 minutes
System Requirements:
Desktops/Laptops
Windows 10
Mac OSX 10.6 higher
Most modern browsers including:
IE 11+
Firefox 18.0+
Chrome latest version
Safari 12+
Mobile/Tablet
iOS devices beginning with OS version 10 or higher (includes, iPhone, ipad and iTouch devices)
Policies
Copyright Policy
Privacy Policy
Contact Us
Contact us at nejmcust@mms.org or (800) 843-6356. Massachusetts Medical Society, 860 Winter Street, Waltham, MA 02451.
